Hypertrophic Cardiomyopathy (HCM) in the majority of cases causes restriction of blood flow in the outflow tract of the heart caused by systolic anterior motion (SAM) of the mitral valve. Dr. Steve Nissen talks with cardiologist Dr. Milind Desai and surgeon Dr. Nick Smedira, Directors of the Hypertrophic Cardiomyopathy Center, about current treatment option ... Show More
Today
2026 Cholesterol Guidelines and What Clinicians Need to Know
Ashish Sarraju, MD, and Leslie Cho, MD, discuss key updates in the 2026 ACC/AHA cholesterol guidelines, including earlier LDL screening and integration of the PREVENT risk calculator. They explore clinical implications of Lp(a) testing, risk stratification and expanding therapeut ... Show More
11m 31s
Jul 2
Post-Transplant Care and Complications in the First Year
Michael Zhen-Yu Tong, MD, and Sanjeeb Bhattacharya, MD, discuss the clinical management of heart transplant patients during the first year, including immunosuppression strategies, rejection surveillance and complication recognition. They also highlight evolving technologies, dono ... Show More
21m 4s
Jun 25
Combined Ablation and Left Atrial Appendage Closure for Atrial Fibrillation
Oussama Wazni, MD, MBA, and Mohamed Kanj, MD, discuss the clinical rationale and outcomes behind combining atrial fibrillation ablation with left atrial appendage closure, including insights from the OPTION trial. They examine patient selection, procedural considerations and the ... Show More
30m 7s
Aug 2024
386. Beyond the Boards: Cardiomyopathies with Dr. Steve Ommen
CardioNerds (Drs. Teodora Donisan, Jenna Skowronski, and Johnny Hourmozdi) discuss Cardiomyopathies with Dr. Steve Ommen. Through a case-based discussion, we review the diagnostic evaluation of suspected restrictive cardiomyopathy, and Dr. Ommen shares his expertise in the nuance ... Show More
37m 30s
Dec 2019
3. Hypertrophic Cardiomyopathy: Case Discussion
The CardioNerds discuss a case of hypertrophic cardiomyopathy teaching a comprehensive approach to pathophysiology, diagnosis, imaging, and management of hypertrophic cardiomyopathy. Guest host, Dr. Fatimah Alkhunaizi. Flutter moment by Dr. Virginia Hahn (Cardiology). On the Card ... Show More
52m 59s
Sep 2025
Sep 12 2025 This Week in Cardiology
More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit ... Show More
31m 5s
<p>In this episode, we review the high-yield topic of Hypertrophic Cardiomyopathy<a href="https://step2.medbullets.com/stats/120393/statistical-hypotheses-and-error"> </a>from the Cardiovascular section.</p>
<p>Follow <a href="https://step1.medbullets.com/">Medbullets</a> on soci ... Show More
